Evidence map›Paper›PMID 41551908›Full record

ArticleCardiovascular therapeutics2026

Correlation Between

Bo Zheng, Meiling Li, Peng Wang, Jialong Lin, Haifeng Pei, Hao Liu, Xianglin Ye

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cardiovascular therapeutics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Correlation BetweenCardiovascular therapeutics · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Bo ZhengDepartment of Neurology, Zigong Third People's Hospital, Zigong, China, www.zgsyy.cn.ORCID https://orcid.org/0000-0002-9601-1905
Meiling LiDepartment of Cardiology, The General Hospital of Western Theater Command, Chengdu, China.ORCID https://orcid.org/0000-0002-9885-0657
Peng WangDepartment of Cardiology, The General Hospital of Western Theater Command, Chengdu, China.ORCID https://orcid.org/0009-0000-3085-5454
Jialong LinDepartment of Emergency Surgery, Yancheng No.1 People's Hospital, Affiliated Hospital of Medical School, Nanjing University, Yancheng, China, nju.edu.cn.ORCID https://orcid.org/0009-0001-2143-5543
Haifeng PeiDepartment of Cardiology, The General Hospital of Western Theater Command, Chengdu, China.ORCID https://orcid.org/0000-0003-1502-8404
Hao LiuDepartment of Cardiology, The General Hospital of Western Theater Command, Chengdu, China.ORCID https://orcid.org/0009-0009-0691-0164
Xianglin YeDepartment of Cardiology, The General Hospital of Western Theater Command, Chengdu, China.ORCID https://orcid.org/0000-0002-3478-9092

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: The objectives of this study is to investigate the correlation between genotype polymorphism of aldehyde dehydrogenase 2 (ALDH2) and coronary artery disease (CAD) in atrial fibrillation patients. Methods: From November 2020 to December 2021, 80 patients with atrial fibrillation at a medical center in Chengdu were divided into two groups: CAD group ( Results: The CAD group showed significantly lower levels of total cholesterol and low-density lipoprotein cholesterol (LDL-C) compared with the non-CAD group ( Conclusions: The polymorphism of ALDH2 gene is a high risk factor for CAD in patients with atrial fibrillation. The ALDH2 mutation genotype (GA + AA) may reduce the lipid-lowering efficacy of statins.

Indexed as

Aldehyde Dehydrogenase, MitochondrialAtrial FibrillationCoronary Artery DiseasePolymorphism, GeneticAgedChinaFemaleGenetic Predisposition to DiseaseHumansMaleMiddle AgedPhenotypeRisk AssessmentRisk FactorsAldehyde Dehydrogenase, MitochondrialALDH2 protein, humanacetaldehyde dehydrogenase 2atrial fibrillationcoronary artery diseasegenotypic polymorphismstatins

Identifiers

PMID41551908
PMCPMC12808927

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.